219 related articles for article (PubMed ID: 15717863)
1. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
[TBL] [Abstract][Full Text] [Related]
2. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism.
Mutch DM; Klocke B; Morrison P; Murray CA; Henderson CJ; Seifert M; Williamson G
J Proteome Res; 2007 Oct; 6(10):3976-84. PubMed ID: 17722906
[TBL] [Abstract][Full Text] [Related]
3. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
Weng Y; DiRusso CC; Reilly AA; Black PN; Ding X
J Biol Chem; 2005 Sep; 280(36):31686-98. PubMed ID: 16006652
[TBL] [Abstract][Full Text] [Related]
4. The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity.
Henderson CJ; Pass GJ; Wolf CR
Toxicol Lett; 2006 Mar; 162(1):111-7. PubMed ID: 16343823
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450.
Wu L; Gu J; Cui H; Zhang QY; Behr M; Fang C; Weng Y; Kluetzman K; Swiatek PJ; Yang W; Kaminsky L; Ding X
J Pharmacol Exp Ther; 2005 Jan; 312(1):35-43. PubMed ID: 15328377
[TBL] [Abstract][Full Text] [Related]
6. Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse.
Pass GJ; Carrie D; Boylan M; Lorimore S; Wright E; Houston B; Henderson CJ; Wolf CR
Cancer Res; 2005 May; 65(10):4211-7. PubMed ID: 15899812
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
Henderson CJ; Otto DM; Carrie D; Magnuson MA; McLaren AW; Rosewell I; Wolf CR
J Biol Chem; 2003 Apr; 278(15):13480-6. PubMed ID: 12566435
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
[TBL] [Abstract][Full Text] [Related]
10. Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum.
Cheng X; Zhang Y; Klaassen CD
J Pharmacol Exp Ther; 2014 Oct; 351(1):105-13. PubMed ID: 25034404
[TBL] [Abstract][Full Text] [Related]
11. Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver.
Mutch DM; Crespy V; Clough J; Henderson CJ; Lariani S; Mansourian R; Moulin J; Wolf CR; Williamson G
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G63-72. PubMed ID: 16455785
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis.
Chen J; Murray M; Liddle C; Jiang XM; Farrell GC
Hepatology; 1995 Aug; 22(2):580-7. PubMed ID: 7635428
[TBL] [Abstract][Full Text] [Related]
13. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.
Wu L; Gu J; Weng Y; Kluetzman K; Swiatek P; Behr M; Zhang QY; Zhuo X; Xie Q; Ding X
Genesis; 2003 Aug; 36(4):177-81. PubMed ID: 12929087
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.
Porter TD; Banerjee S; Stolarczyk EI; Zou L
Drug Metab Dispos; 2011 Jun; 39(6):966-73. PubMed ID: 21368239
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profile reveals altered hepatic lipid and cholesterol metabolism in hyposulfatemic NaS1 null mice.
Dawson PA; Gardiner B; Grimmond S; Markovich D
Physiol Genomics; 2006 Jul; 26(2):116-24. PubMed ID: 16621889
[TBL] [Abstract][Full Text] [Related]
17. The role of cytochrome P450-dependent metabolism in the regulation of mouse hepatic growth hormone signaling components and target genes by 3-methylcholanthrene.
Lee C; Ding X; Riddick DS
Drug Metab Dispos; 2013 Feb; 41(2):457-65. PubMed ID: 23169610
[TBL] [Abstract][Full Text] [Related]
18. Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
Weng Y; Fang C; Turesky RJ; Behr M; Kaminsky LS; Ding X
Cancer Res; 2007 Aug; 67(16):7825-32. PubMed ID: 17699788
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.
Tydén E; Olsén L; Tallkvist J; Tjälve H; Larsson P
Res Vet Sci; 2008 Aug; 85(1):80-5. PubMed ID: 17980394
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb.
Schmidt K; Hughes C; Chudek JA; Goodyear SR; Aspden RM; Talbot R; Gundersen TE; Blomhoff R; Henderson C; Wolf CR; Tickle C
Mol Cell Biol; 2009 May; 29(10):2716-29. PubMed ID: 19273610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
